Last reviewed · How we verify
NCT05720416
Effects of a Multi-intervention Programme for the Elderly
NA trial testing protein supplementation in Sarcopenia in 207 participants. Completed in 31 December 2024.
30 August 2024
Quick facts
| Lead sponsor | Central Taiwan University of Science and Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 207 |
| Start date | 22 August 2023 |
| Primary completion | 30 August 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- protein supplementation
- muscle strength training
- usual care
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
- Sarcopenic Obesity — all drugs for Sarcopenic Obesity →
- Dementia — all drugs for Dementia →
Sponsor
Central Taiwan University of Science and Technology
Who can join
60 and older, any sex, with Sarcopenia or Sarcopenic Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1\. To develop a multiactivity training programme. 2. To explore the effect of this programme on sarcopenia, sarcopenic obesity, cognitive impairment and Parkinson's disease. 3. To compare the effects of the experimental and control treatments on the muscle strength, body composition, physical function performance and quality of life of the elderly.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05720416
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of protein supplementation
Trials testing the same drug.
- NCT06459609 — Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment · NA · completed
- NCT02712086 — Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery · NA · completed
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Other Central Taiwan University of Science and Technology trials
Trials by the same sponsor.
- NCT07318246 — Team Work and Creative Self-Efficacy · NA · recruiting
- NCT06550661 — Effects of Ba Duan Jin Training for Older People · NA · completed
- NCT06015139 — Preventing Pressure Injuries in Patients Undergoing Lumbar Spine Surgery · NA · completed
- NCT05543538 — Influence of Different Teaching Strategies on the Academic Performance and Caring of Nursing Students · NA · completed
- NCT04204187 — Developing and Validating the Caring Questionnaire of Service Learning Courses · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05720416 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Taiwan University of Science and Technology
- Last refreshed: 12 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05720416.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing